Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Q-linea AB ( (SE:QLINEA) ).
Q-linea AB has announced an increase in its number of shares and votes following the exercise of TO1 warrants, resulting in a total of 6,430,039,725 shares. This expansion reflects the company’s growth and could enhance its market presence, impacting stakeholders by potentially increasing shareholder value.
More about Q-linea AB
Q-linea is a company specializing in rapid antimicrobial susceptibility testing (AST) systems, particularly the ASTar® system, which aids hospitals in quickly identifying optimal antimicrobial therapies for bloodstream infections and sepsis. The company is based in Uppsala, Sweden, with regional offices in Italy and the USA, and has a global partnership network. Their products are CE-IVD marked and FDA 510(k) cleared.
Average Trading Volume: 35,194,265
Current Market Cap: SEK200.6M
For detailed information about QLINEA stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue